Antonio Cabal is currently a Director, Quantitative Systems Pharmacology, at Eisai Inc., Exton, PA. He took his Bachelor of Science degree in Mechanics and Mathematics from Lomonosov Moscow State University, Moscow, Russia. Following his undergraduate work, he worked on ocean circulation models at Havana's Institute of Oceanology, in Havana, Cuba before beginning graduate studies in computational fluid dynamics. He completed a Master of Science at Simon Fraser University in Vancouver, B.C., and his Ph.D. at the University of Western Ontario, in London, Ontario, Canada, both in Applied Mathematics. He then spent seven years with the Eastman Kodak Research Labs in Rochester, New York, applying mathematical models and computational simulations to multi-physic problems associated with micro-electro-mechanical systems (MEMS) design and optimization for inkjet printer. In January 2005 Dr. Cabal took a position as Scientist/Associate Disease Manager at Archimedes, Inc., where he developed mathematical models of human physiology and its interaction with the health care system to guide health care policy. In August 2006 he joined Merck where for 14 years he held various positions of increasing responsibility leading multidisciplinary teams working on the scientific development and implementation of Quantitative System Pharmacology (QSP) models.